Cargando…

PI3K Pathway in NSCLC

The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of intracellular lipid kinases that phosphorylate the 3′-hydroxyl group of phosphatidylinositol and phosphoinositides. PI3K regulate signaling pathways for neoplasia, including cell proliferation, adhesion, survival, and motility. Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Martí, Alex, Felip, Enriqueta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356073/
https://www.ncbi.nlm.nih.gov/pubmed/22655251
http://dx.doi.org/10.3389/fonc.2011.00055
_version_ 1782233493906915328
author Martinez-Martí, Alex
Felip, Enriqueta
author_facet Martinez-Martí, Alex
Felip, Enriqueta
author_sort Martinez-Martí, Alex
collection PubMed
description The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of intracellular lipid kinases that phosphorylate the 3′-hydroxyl group of phosphatidylinositol and phosphoinositides. PI3K regulate signaling pathways for neoplasia, including cell proliferation, adhesion, survival, and motility. Different classes of PI3K have distinct roles in cellular signal transduction. PI3K pathway is activated by several different mechanisms in cancers, including, somatic mutation and gene amplification. In this review, we examine the literature addressing PI3K mutation status and gene amplification, with an emphasis on non-small cell lung cancer.
format Online
Article
Text
id pubmed-3356073
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33560732012-05-31 PI3K Pathway in NSCLC Martinez-Martí, Alex Felip, Enriqueta Front Oncol Oncology The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of intracellular lipid kinases that phosphorylate the 3′-hydroxyl group of phosphatidylinositol and phosphoinositides. PI3K regulate signaling pathways for neoplasia, including cell proliferation, adhesion, survival, and motility. Different classes of PI3K have distinct roles in cellular signal transduction. PI3K pathway is activated by several different mechanisms in cancers, including, somatic mutation and gene amplification. In this review, we examine the literature addressing PI3K mutation status and gene amplification, with an emphasis on non-small cell lung cancer. Frontiers Research Foundation 2012-01-06 /pmc/articles/PMC3356073/ /pubmed/22655251 http://dx.doi.org/10.3389/fonc.2011.00055 Text en Copyright © 2012 Martinez-Martí and Felip. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Oncology
Martinez-Martí, Alex
Felip, Enriqueta
PI3K Pathway in NSCLC
title PI3K Pathway in NSCLC
title_full PI3K Pathway in NSCLC
title_fullStr PI3K Pathway in NSCLC
title_full_unstemmed PI3K Pathway in NSCLC
title_short PI3K Pathway in NSCLC
title_sort pi3k pathway in nsclc
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356073/
https://www.ncbi.nlm.nih.gov/pubmed/22655251
http://dx.doi.org/10.3389/fonc.2011.00055
work_keys_str_mv AT martinezmartialex pi3kpathwayinnsclc
AT felipenriqueta pi3kpathwayinnsclc